The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 23, 2010

Filed:

Jun. 29, 2005
Applicants:

Gerald E. Hancock, New City, NY (US);

Matthew B. Elliott, Branford, CT (US);

Inventors:

Gerald E. Hancock, New City, NY (US);

Matthew B. Elliott, Branford, CT (US);

Assignee:

Wyeth Holdings Corporation, Madison, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/155 (2006.01); A61K 39/295 (2006.01); A61K 31/7105 (2006.01); C12N 7/00 (2006.01); C12N 7/01 (2006.01); C12N 5/10 (2006.01); C12N 15/86 (2006.01); C12N 15/63 (2006.01); C12N 15/45 (2006.01);
U.S. Cl.
CPC ...
Abstract

The construction of recombinant respiratory syncytial virus (RSV) strains deleted of the region of G protein most likely to induce unwanted type 2 T cell responses in susceptible recipients is disclosed. Using reverse genetics, recombinant RSV strains were engineered with deletions of amino acids 151-221 and 178-219. Both RSV strains replicated in the respiratory tract of BALB/c mice and elicited serum neutralization and anti-F protein IgG titers that were equivalent to cp-RSV and contributed to a 3.9 logreduction in RSV A2 four days after challenge. Importantly, pulmonary eosinophilia was significantly diminished in BALB/c mice primed with native G protein and challenged with either recombinant RSV strain. These findings are important for the development of immunogenic compositions against RSV.


Find Patent Forward Citations

Loading…